Top Stories

• 

  Skipping Diversity Suits Lets Error 'Metastasize,' Alito Says

  By Katie Buehler

  The U.S. Supreme Court declined Monday to review Boston's allegedly discriminatory COVID-19 pandemic-era admissi...(read more)

• 

  FDIC Asked Banks To 'Pause' Crypto Activity, Letters Show

  By Aislinn Keely

  The Federal Deposit Insurance Corp. directed some financial institutions to pause cryptocurrency-related activit...(read more)

ADVERTISEMENT


• Menendez Verdict Wasn't Tainted By Evidence Error, Feds Say

  By Elliot Weld

  Prosecutors told a Manhattan federal judge that evidence that was mistakenly loaded onto a laptop given to the jury that convicted former Sen. Bob Menendez, D-N.J., of bribery charges most likely wasn't seen by the jurors and didn't impact their verdict in a way that would merit a new trial.

• Paul Hastings, Paul Weiss Lead $6.7B Pactiv Evergreen Sale

  By Jade Martinez-Pogue

  Packaging products maker Novolex, advised by Paul Weiss Rifkind Wharton & Garrison LLP, on Monday announced that it will combine with food merchandising product manufacturer Pactiv Evergreen, led by Paul Hastings LLP, in a $6.7 billion take-private deal that is backed by private equity funds.

• NYC Council Sues Mayor For Not Enforcing Jail Abuse Ban

  By Frank G. Runyeon

  The New York City Council sued Mayor Eric Adams on Monday for failing to end the use of solitary confinement in city jails after the lawmaking body passed a bill banning the practice earlier this year, arguing that his "emergency" order violated the separation of powers.

• Arthur J Gallagher Buying AssuredPartners For $13.5B

  By Al Barbarino

  Arthur J. Gallagher & Co. has agreed to purchase independent insurance brokerage AssuredPartners for $13.5 billion in cash, in what its seller, private equity firm GTCR, said will be the largest sale of a U.S. insurance broker to a strategic acquiror in the history of the industry.

• Justices Spurn Worker's Challenge To 'Honest Belief' Firing

  By Ryan Harroff

  The U.S. Supreme Court has declined to review a Fourth Circuit decision holding that a Baltimore utility's "honest belief" that a worker was misusing medical leave justified the employee's termination, according to high court orders released Monday.

• Justices Won't Review Massive Class In Fringe Benefits Fight

  By Kellie Mejdrich

  The U.S. Supreme Court refused Monday to hear a challenge to a 290,000-worker class in a suit alleging excessive health and retirement plan fees, despite an argument from benefits plan managers that the Fifth Circuit used the wrong standard to greenlight the massive suit.

• Trump Names His Personal Atty As Counselor

  By Carla Baranauckas

  The New Jersey-based litigator who represented Donald Trump in suits that saddled him with multimillion-dollar civil judgments will serve as his counselor when he returns to the White House, the president-elect said Sunday in announcing a new round of picks for his upcoming administration.

• Up Next: Environmental Reviews, Wire Fraud & TM Awards

  By Katie Buehler

  The U.S. Supreme Court will hear its final set of oral arguments for the 2024 calendar year starting Monday, including disputes over the proper scope of federal environmental reviews and whether corporate affiliates can be ordered to pay disgorgement awards in trademark infringement disputes.

• DC Circ. Ruling Far From Last Word On Looming TikTok Ban

  By Allison Grande

  The D.C. Circuit's decision Friday paving the way for a U.S. ban on TikTok to take effect next month sparked immediate concerns about the loss of a social platform that millions rely on to freely express themselves, but a likely appeal and upcoming administration change could end up flipping the script.

• How Paul Atkins' Last SEC Term Might Shape Agency's Future

  By Jessica Corso

  President-elect Donald Trump's choice to lead the U.S. Securities and Exchange Commission next year is no stranger to the agency, and Paul Atkins' past speeches, statements and actions as a commissioner may offer a road map for how he would lead the agency in areas such as private funds, shareholder activism and multibillion-dollar enforcement sweeps.

• Galderma Can't Undo Lupin's Skin Drug Win At Fed. Circ.

  By Andrew Karpan

  Federal Circuit judges on Friday upheld a bench trial finding earlier this year that allowed an Indian generic-drug maker to start selling a treatment for a chronic skin condition that competes with a brand developed by Swiss skin care giant Galderma.

• High Court To Weigh $47M TM Award Liability For Non-Parties

  By Ivan Moreno

  A trademark case before the U.S. Supreme Court Wednesday will delve into whether corporate affiliates of a real estate development company should be liable for an infringement judgment of nearly $47 million, even though they were not named defendants in the litigation.